Back to Journals » Biologics: Targets and Therapy » Volume 7

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]

Authors Lurati A, Bertani L, Marrazza M, Re KA, Bompane D, Scarpellini M

Received 19 June 2013

Accepted for publication 19 June 2013

Published 6 December 2013 Volume 2013:7 Pages 265—266

DOI https://doi.org/10.2147/BTT.S50190

 

Lurati A, Bertani L, Marrazza M, Re KA, Bompane D, Scarpellini M. Biologics: Targets and Therapy. 2012;6:83–87.
On page 87, the disclosure was listed as ‘The authors report no conflicts of interest in this work.’ in error. The correct disclosure should be ‘An unrestricted publication grant was provided by Roche S.p.A. The authors have no other conflicts of interest to report.’

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

The macrophages in rheumatic diseases

Laria A, Lurati A, Marrazza M, Mazzocchi D, Re KA, Scarpellini M

Journal of Inflammation Research 2016, 9:1-11

Published Date: 9 February 2016

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab

Lurati A, Bertani L, Marrazza M, Re KA, Bompane D, Scarpellini M

Biologics: Targets and Therapy 2012, 6:83-87

Published Date: 11 April 2012

Safety of etanercept in elderly subjects with rheumatoid arthritis

Alfredomaria Lurati, Mariagrazia Marrazza, Katia Angela, et al

Biologics: Targets and Therapy 2010, 4:1-4

Published Date: 22 December 2009

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010